IP Library Assignment 025689/0743
Patent Assignment
Reel/Frame 025689/0743

Change of Name

Recorded: 2011-01-25 Pages: 5
Assignor
SEPRACOR INC.
Executed: 2010-10-12
Assignee
SUNOVION PHARMACEUTICALS INC.
84 WATERFORD DRIVE, MARLBOROUGH, MASSACHUSETTS, 01752-7010
Covered Properties (19)
Methods for Treating Allergic Disorders Using Optically Pure(-) Cetirizine
Patent: 5,698,558 →
Application: 08/789,502 →
Lactose-Free, Non-Hygroscopic and Anhydrous Pharmaceutical Compositions of Descarboethoxyloratadine
Application: 09/019,955 →
Compositions of Descarboethoxyloratadine
Patent: 7,214,683 →
Application: 09/039,260 →
Methods and Compositions Using Terfenadine Metabolites in Combination with Leukotriene Inhibitors
Patent: 6,194,431 →
Application: 09/059,570 →
Methods and Compositions Using Cetirizine in Combination with Leukotriene Inhibitors or Decongestants
Patent: 6,384,038 →
Application: 09/059,571 →
Formoterol Process
Patent: 6,040,344 →
Application: 09/083,010 →
Desformoterol and Process for Its Preparation
Patent: 5,965,622 →
Application: 09/103,212 →
Desformoterol Compositions Useful for Inducing Broncodilation
Patent: 6,071,971 →
Application: 09/305,534 →
Methods for Treating Urticaria Using Descarboethoxyloratadine
Patent: 7,211,582 →
Application: 09/447,218 →
Derivatives of (-)- Venlafaxine and Methods of Preparing and Using the Same
Patent: 6,342,533 →
Application: 09/450,690 →
Formoterol process
Patent: 6,268,533 →
Application: 09/493,042 →
Methods and Compositions Using Terfenadine Metabolities in Combination with Leukotriene Inhibitors
Patent: 6,509,353 →
Application: 09/722,395 →
Methods of Treating Affective Disorders Using Derivatives of (-)- Venlafaxine
Patent: 6,441,048 →
Application: 10/014,592 →
Publication: US 2002/0086904
Methods and Compositions Using Optically Pure(-) Cetirizine in Combination with Leukotriene Inhibitors or Decongestants
Patent: 6,790,849 →
Application: 10/105,331 →
Publication: US 2002/0099058
Methods of Treating and Preventing Pain, Anxiety, and Incontinence Using Derivatives of (-)-Venlafaxine
Patent: 6,911,479 →
Application: 10/222,815 →
Publication: US 2003/0018083
Methods and compositions using racemic, (R)-, And (S)- Fexofenadine in combination with leukotriene inhibitors
Application: 10/314,269 →
Publication: US 2003/0083343
Derivatives of (-)- and (+)-venlafaxine and methods of preparing and using the same
Application: 10/806,423 →
Publication: US 2004/0180952
Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants
Application: 10/939,382 →
Publication: US 2005/0032815
Methods for the Treatment of Allergic Rhinitis
Patent: 7,214,684 →
Application: 10/989,514 →
Publication: US 2005/0131046
Related Assignments (8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 6, 1998
From: REDMON, MARTIN P.; BUTLER, HAL T.; WALD, STEPHEN A.; RUBIN, PAUL D.
To: SEPRACOR, INC.
Reel/Frame 008971/0263 →
Assignment of Assignor's Interest Jun 12, 1998
From: RUBIN, PAUL D.
To: SEPRACOR INC.
Reel/Frame 009335/0020 →
Assignment of Assignor's Interest Jun 23, 1998
From: SENANAYAKE, CHRIS HUGH
To: SEPRACOR, INC.
Reel/Frame 009295/0744 →
Assignment of Assignor's Interest Jul 6, 1998
From: RUBIN, PAUL D.
To: SEPRACOR INC.
Reel/Frame 009334/0818 →
Assignment of Assignor's Interest Aug 12, 1998
From: GAO, YUN; FANG, KEVIN Q.; HETT, ROBERT; REDMON, MARTIN PATRICK
To: SEPRACOR, INC.
Reel/Frame 009377/0216 →
Assignment of Assignor's Interest Feb 10, 2000
From: JERUSSI, THOMAS P.; SENANAYAKE, CHRISANTHA H.
To: SEPRACOR INC.
Reel/Frame 010593/0534 →
Assignment of Assignor's Interest Jun 12, 2001
From: JERUSSI, THOMAS P.; SENANAYAKE, CHISANTHA H.; BHONGLE, NANDKUMAR N.
To: SEPRACOR, INC.
Reel/Frame 011896/0345 →
Change of Name Nov 24, 2010
From: SEPRACOR INC.
To: SUNOVION PHARMACEUTICALS INC.
Reel/Frame 025521/0941 →